Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response

Yinfang Wang, Yanli Hou, Weiwei Zhang, Angel A Alvarez, Yongrui Bai, Bo Hu, Shi-Yuan Cheng, Kun Yang, Yanxin Li, Haizhong Feng

Research output: Contribution to journalArticle

Abstract

Background: Ionizing radiation (IR) therapy is the standard first-line treatment for newly diagnosed patients with glioblastoma (GBM), the most common and malignant primary brain tumor. However, the effects of IR are limited due to the aberrant radioresistance of GBM. Methods: Transcriptome analysis was performed using RNA-seq in radioresistant patient-derived glioma stem-like cells (GSCs). Survival of glioma patient and mice bearing-brain tumors was analyzed by Kaplan-Meier survival analysis. Lipid droplet and γ-H2AX foci-positive cells were evaluated using immunofluorescence staining. Results: Lipolytic inhibitor G0/G1 switch gene 2 (G0S2) is upregulated in radioresistant GSCs and elevated in clinical GBM. GBM patients with high G0S2 expression had significantly shorter overall survival compared with those with low expression of G0S2. Using genetic approaches targeting G0S2 in glioma cells and GSCs, we found that knockdown of G0S2 promoted lipid droplet turnover, inhibited GSC radioresistance, and extended survival of xenograft tumor mice with or without IR. In contrast, overexpression of G0S2 promoted glioma cell radiation resistance. Mechanistically, high expression of G0S2 reduced lipid droplet turnover and thereby attenuated E3 ligase RNF168-mediated 53BP1 ubiquitination through activated the mechanistic target of rapamycin (mTOR)-ribosomal S6 kinase (S6K) signaling and increased 53BP1 protein stability in response to IR, leading to enhanced DNA repair and glioma radioresistance. Conclusions: Our findings uncover a new function for lipolytic inhibitor G0S2 as an important regulator for GSC radioresistance, suggesting G0S2 as a potential therapeutic target for treating gliomas.

Original languageEnglish (US)
Article number147
JournalJournal of Experimental and Clinical Cancer Research
Volume38
Issue number1
DOIs
StatePublished - Apr 5 2019

Fingerprint

Switch Genes
Glioma
Stem Cells
Radiation
Glioblastoma
Ionizing Radiation
Brain Neoplasms
Ribosomal Protein S6 Kinases
Background Radiation
Ubiquitin-Protein Ligases
Survival
Protein Stability
Ubiquitination
Kaplan-Meier Estimate
Gene Expression Profiling
Sirolimus
Survival Analysis
Heterografts
DNA Repair
Fluorescent Antibody Technique

Keywords

  • 53BP1
  • G0/G1 switch gene 2 (G0S2)
  • Glioma stem cell (GSCs)
  • Radioresistance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Wang, Yinfang ; Hou, Yanli ; Zhang, Weiwei ; Alvarez, Angel A ; Bai, Yongrui ; Hu, Bo ; Cheng, Shi-Yuan ; Yang, Kun ; Li, Yanxin ; Feng, Haizhong. / Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response. In: Journal of Experimental and Clinical Cancer Research. 2019 ; Vol. 38, No. 1.
@article{1b68b0a404b444338f9396c31151841a,
title = "Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response",
abstract = "Background: Ionizing radiation (IR) therapy is the standard first-line treatment for newly diagnosed patients with glioblastoma (GBM), the most common and malignant primary brain tumor. However, the effects of IR are limited due to the aberrant radioresistance of GBM. Methods: Transcriptome analysis was performed using RNA-seq in radioresistant patient-derived glioma stem-like cells (GSCs). Survival of glioma patient and mice bearing-brain tumors was analyzed by Kaplan-Meier survival analysis. Lipid droplet and γ-H2AX foci-positive cells were evaluated using immunofluorescence staining. Results: Lipolytic inhibitor G0/G1 switch gene 2 (G0S2) is upregulated in radioresistant GSCs and elevated in clinical GBM. GBM patients with high G0S2 expression had significantly shorter overall survival compared with those with low expression of G0S2. Using genetic approaches targeting G0S2 in glioma cells and GSCs, we found that knockdown of G0S2 promoted lipid droplet turnover, inhibited GSC radioresistance, and extended survival of xenograft tumor mice with or without IR. In contrast, overexpression of G0S2 promoted glioma cell radiation resistance. Mechanistically, high expression of G0S2 reduced lipid droplet turnover and thereby attenuated E3 ligase RNF168-mediated 53BP1 ubiquitination through activated the mechanistic target of rapamycin (mTOR)-ribosomal S6 kinase (S6K) signaling and increased 53BP1 protein stability in response to IR, leading to enhanced DNA repair and glioma radioresistance. Conclusions: Our findings uncover a new function for lipolytic inhibitor G0S2 as an important regulator for GSC radioresistance, suggesting G0S2 as a potential therapeutic target for treating gliomas.",
keywords = "53BP1, G0/G1 switch gene 2 (G0S2), Glioma stem cell (GSCs), Radioresistance",
author = "Yinfang Wang and Yanli Hou and Weiwei Zhang and Alvarez, {Angel A} and Yongrui Bai and Bo Hu and Shi-Yuan Cheng and Kun Yang and Yanxin Li and Haizhong Feng",
year = "2019",
month = "4",
day = "5",
doi = "10.1186/s13046-019-1151-x",
language = "English (US)",
volume = "38",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central",
number = "1",

}

Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response. / Wang, Yinfang; Hou, Yanli; Zhang, Weiwei; Alvarez, Angel A; Bai, Yongrui; Hu, Bo; Cheng, Shi-Yuan; Yang, Kun; Li, Yanxin; Feng, Haizhong.

In: Journal of Experimental and Clinical Cancer Research, Vol. 38, No. 1, 147, 05.04.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response

AU - Wang, Yinfang

AU - Hou, Yanli

AU - Zhang, Weiwei

AU - Alvarez, Angel A

AU - Bai, Yongrui

AU - Hu, Bo

AU - Cheng, Shi-Yuan

AU - Yang, Kun

AU - Li, Yanxin

AU - Feng, Haizhong

PY - 2019/4/5

Y1 - 2019/4/5

N2 - Background: Ionizing radiation (IR) therapy is the standard first-line treatment for newly diagnosed patients with glioblastoma (GBM), the most common and malignant primary brain tumor. However, the effects of IR are limited due to the aberrant radioresistance of GBM. Methods: Transcriptome analysis was performed using RNA-seq in radioresistant patient-derived glioma stem-like cells (GSCs). Survival of glioma patient and mice bearing-brain tumors was analyzed by Kaplan-Meier survival analysis. Lipid droplet and γ-H2AX foci-positive cells were evaluated using immunofluorescence staining. Results: Lipolytic inhibitor G0/G1 switch gene 2 (G0S2) is upregulated in radioresistant GSCs and elevated in clinical GBM. GBM patients with high G0S2 expression had significantly shorter overall survival compared with those with low expression of G0S2. Using genetic approaches targeting G0S2 in glioma cells and GSCs, we found that knockdown of G0S2 promoted lipid droplet turnover, inhibited GSC radioresistance, and extended survival of xenograft tumor mice with or without IR. In contrast, overexpression of G0S2 promoted glioma cell radiation resistance. Mechanistically, high expression of G0S2 reduced lipid droplet turnover and thereby attenuated E3 ligase RNF168-mediated 53BP1 ubiquitination through activated the mechanistic target of rapamycin (mTOR)-ribosomal S6 kinase (S6K) signaling and increased 53BP1 protein stability in response to IR, leading to enhanced DNA repair and glioma radioresistance. Conclusions: Our findings uncover a new function for lipolytic inhibitor G0S2 as an important regulator for GSC radioresistance, suggesting G0S2 as a potential therapeutic target for treating gliomas.

AB - Background: Ionizing radiation (IR) therapy is the standard first-line treatment for newly diagnosed patients with glioblastoma (GBM), the most common and malignant primary brain tumor. However, the effects of IR are limited due to the aberrant radioresistance of GBM. Methods: Transcriptome analysis was performed using RNA-seq in radioresistant patient-derived glioma stem-like cells (GSCs). Survival of glioma patient and mice bearing-brain tumors was analyzed by Kaplan-Meier survival analysis. Lipid droplet and γ-H2AX foci-positive cells were evaluated using immunofluorescence staining. Results: Lipolytic inhibitor G0/G1 switch gene 2 (G0S2) is upregulated in radioresistant GSCs and elevated in clinical GBM. GBM patients with high G0S2 expression had significantly shorter overall survival compared with those with low expression of G0S2. Using genetic approaches targeting G0S2 in glioma cells and GSCs, we found that knockdown of G0S2 promoted lipid droplet turnover, inhibited GSC radioresistance, and extended survival of xenograft tumor mice with or without IR. In contrast, overexpression of G0S2 promoted glioma cell radiation resistance. Mechanistically, high expression of G0S2 reduced lipid droplet turnover and thereby attenuated E3 ligase RNF168-mediated 53BP1 ubiquitination through activated the mechanistic target of rapamycin (mTOR)-ribosomal S6 kinase (S6K) signaling and increased 53BP1 protein stability in response to IR, leading to enhanced DNA repair and glioma radioresistance. Conclusions: Our findings uncover a new function for lipolytic inhibitor G0S2 as an important regulator for GSC radioresistance, suggesting G0S2 as a potential therapeutic target for treating gliomas.

KW - 53BP1

KW - G0/G1 switch gene 2 (G0S2)

KW - Glioma stem cell (GSCs)

KW - Radioresistance

UR - http://www.scopus.com/inward/record.url?scp=85064056594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064056594&partnerID=8YFLogxK

U2 - 10.1186/s13046-019-1151-x

DO - 10.1186/s13046-019-1151-x

M3 - Article

VL - 38

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 1

M1 - 147

ER -